Which has better valuation and earnings, VCT or ZTF?

Victrex has higher revenue and earnings than Zotefoams. Victrex is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Victrex £296.40M 2.07 £30.80M -£22.40 N/A Zotefoams £158.49M 1.33 £9.80M £44.87 9.58

Is VCT or ZTF more profitable?

Zotefoams has a net margin of 14.28% compared to Victrex's net margin of -6.70%. Zotefoams' return on equity of 18.25% beat Victrex's return on equity. Company Net Margins Return on Equity Return on Assets Victrex -6.70% -4.95% 6.59% Zotefoams 14.28% 18.25% 5.48%

Does the media favor VCT or ZTF?

In the previous week, Victrex and Victrex both had 1 articles in the media. Zotefoams' average media sentiment score of 1.61 beat Victrex's score of 0.85 indicating that Zotefoams is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Victrex 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zotefoams 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate ZTF or SCPA?

Zotefoams currently has a consensus target price of GBX 605, suggesting a potential upside of 40.70%. Given Zotefoams' stronger consensus rating and higher probable upside, equities research analysts plainly believe Zotefoams is more favorable than Scapa Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zotefoams 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, ZTF or ESNT?

Zotefoams has higher earnings, but lower revenue than Essentra. Zotefoams is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £158.49M 1.33 £9.80M £44.87 9.58 Essentra £302M 0.83 £3.50M £0.70 127.00

Is ZTF or ESNT more profitable?

Zotefoams has a net margin of 14.28% compared to Essentra's net margin of 0.70%. Zotefoams' return on equity of 18.25% beat Essentra's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 14.28% 18.25% 5.48% Essentra 0.70% 0.79% 1.74%

Does the media refer more to ZTF or ESNT?

In the previous week, Zotefoams and Zotefoams both had 1 articles in the media. Zotefoams' average media sentiment score of 1.61 beat Essentra's score of 1.11 indicating that Zotefoams is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zotefoams 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Essentra 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, ZTF or TET?

Treatt has lower revenue, but higher earnings than Zotefoams. Zotefoams is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £158.49M 1.33 £9.80M £44.87 9.58 Treatt £128.29M 1.40 £11.22M £7.22 42.24

Is ZTF or TET more profitable?

Zotefoams has a net margin of 14.28% compared to Treatt's net margin of 3.40%. Zotefoams' return on equity of 18.25% beat Treatt's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 14.28% 18.25% 5.48% Treatt 3.40% 3.22% 6.72%

Which has preferable earnings & valuation, SYNT or ZTF?

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.74B 0.08 -£82.04M -£96.00 N/A Zotefoams £158.49M 1.33 £9.80M £44.87 9.58

Is SYNT or ZTF more profitable?

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -9.03%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -9.03% -16.66% -0.28% Zotefoams 14.28% 18.25% 5.48%

Does the media favor SYNT or ZTF?

In the previous week, Synthomer had 1 more articles in the media than Zotefoams. MarketBeat recorded 2 mentions for Synthomer and 1 mentions for Zotefoams. Zotefoams' average media sentiment score of 1.61 beat Synthomer's score of 0.34 indicating that Zotefoams is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synthomer 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zotefoams 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Zotefoams (ZTF) Competitors

GBX 430 0.00 (0.00%)

As of 07/20/2026 12:20 PM Eastern

Compare

ZTF vs. VCT, SCPA, ESNT, TET, and SYNT

Should you buy Zotefoams stock or one of its competitors? MarketBeat compares Zotefoams with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zotefoams include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), and Synthomer (SYNT). These companies are all part of the "specialty chemicals" industry.

How does Zotefoams compare to Victrex?

Victrex (LON:VCT) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

Zotefoams has a net margin of 14.28% compared to Victrex's net margin of -6.70%. Zotefoams' return on equity of 18.25% beat Victrex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Victrex	-6.70%	-4.95%	6.59%
Zotefoams	14.28%	18.25%	5.48%

Victrex presently has a consensus target price of GBX 663.33, indicating a potential downside of 5.64%. Zotefoams has a consensus target price of GBX 605, indicating a potential upside of 40.70%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts clearly believe Zotefoams is more favorable than Victrex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Victrex	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Victrex pays an annual dividend of GBX 59.56 per share and has a dividend yield of 8.5%. Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 1.8%. Victrex pays out -265.9% of its earnings in the form of a dividend. Zotefoams pays out 16.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Victrex is clearly the better dividend stock, given its higher yield and lower payout ratio.

Victrex has higher revenue and earnings than Zotefoams. Victrex is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Victrex	£296.40M	2.07	£30.80M	-£22.40	N/A
Zotefoams	£158.49M	1.33	£9.80M	£44.87	9.58

In the previous week, Victrex and Victrex both had 1 articles in the media. Zotefoams' average media sentiment score of 1.61 beat Victrex's score of 0.85 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Victrex	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zotefoams	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

75.5% of Victrex shares are held by institutional investors. Comparatively, 29.4% of Zotefoams shares are held by institutional investors. 4.2% of Victrex shares are held by company insiders. Comparatively, 4.5% of Zotefoams shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Victrex has a beta of 0.774, suggesting that its share price is 23% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.239, suggesting that its share price is 24% more volatile than the broader market.

Summary

Zotefoams beats Victrex on 10 of the 17 factors compared between the two stocks.

How does Zotefoams compare to Scapa Group?

Zotefoams (LON:ZTF) and Scapa Group (LON:SCPA) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Zotefoams has higher earnings, but lower revenue than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£158.49M	1.33	£9.80M	£44.87	9.58
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A

In the previous week, Zotefoams had 1 more articles in the media than Scapa Group. MarketBeat recorded 1 mentions for Zotefoams and 0 mentions for Scapa Group. Zotefoams' average media sentiment score of 1.61 beat Scapa Group's score of 0.00 indicating that Zotefoams is being referred to more favorably in the media.

Company	Overall Sentiment
Zotefoams	Very Positive
Scapa Group	Neutral

29.4% of Zotefoams shares are held by institutional investors. 4.5% of Zotefoams shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Zotefoams currently has a consensus target price of GBX 605, suggesting a potential upside of 40.70%. Given Zotefoams' stronger consensus rating and higher probable upside, equities research analysts plainly believe Zotefoams is more favorable than Scapa Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Zotefoams has a net margin of 14.28% compared to Scapa Group's net margin of 0.00%. Zotefoams' return on equity of 18.25% beat Scapa Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Scapa Group	N/A	N/A	N/A

Summary

Zotefoams beats Scapa Group on 12 of the 13 factors compared between the two stocks.

How does Zotefoams compare to Essentra?

Zotefoams (LON:ZTF) and Essentra (LON:ESNT) are both small-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

Zotefoams has higher earnings, but lower revenue than Essentra. Zotefoams is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£158.49M	1.33	£9.80M	£44.87	9.58
Essentra	£302M	0.83	£3.50M	£0.70	127.00

Zotefoams has a net margin of 14.28% compared to Essentra's net margin of 0.70%. Zotefoams' return on equity of 18.25% beat Essentra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Essentra	0.70%	0.79%	1.74%

Zotefoams has a beta of 1.239, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Essentra has a beta of 0.829, indicating that its stock price is 17% less volatile than the broader market.

29.4% of Zotefoams shares are owned by institutional investors. Comparatively, 69.5% of Essentra shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Comparatively, 0.5% of Essentra shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 1.8%. Essentra pays an annual dividend of GBX 2.35 per share and has a dividend yield of 2.6%. Zotefoams pays out 16.9% of its earnings in the form of a dividend. Essentra pays out 335.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Zotefoams presently has a consensus price target of GBX 605, suggesting a potential upside of 40.70%. Essentra has a consensus price target of GBX 150, suggesting a potential upside of 68.73%. Given Essentra's higher possible upside, analysts plainly believe Essentra is more favorable than Zotefoams.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Essentra	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

In the previous week, Zotefoams and Zotefoams both had 1 articles in the media. Zotefoams' average media sentiment score of 1.61 beat Essentra's score of 1.11 indicating that Zotefoams is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zotefoams	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Essentra	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Zotefoams beats Essentra on 11 of the 17 factors compared between the two stocks.

How does Zotefoams compare to Treatt?

Zotefoams (LON:ZTF) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Zotefoams has a beta of 1.239, meaning that its share price is 24% more volatile than the broader market. Comparatively, Treatt has a beta of 0.907, meaning that its share price is 9% less volatile than the broader market.

Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 1.8%. Treatt pays an annual dividend of GBX 5.60 per share and has a dividend yield of 1.8%. Zotefoams pays out 16.9% of its earnings in the form of a dividend. Treatt pays out 77.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Zotefoams currently has a consensus target price of GBX 605, indicating a potential upside of 40.70%. Treatt has a consensus target price of GBX 248.33, indicating a potential downside of 18.58%. Given Zotefoams' stronger consensus rating and higher possible upside, research analysts plainly believe Zotefoams is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Zotefoams had 1 more articles in the media than Treatt. MarketBeat recorded 1 mentions for Zotefoams and 0 mentions for Treatt. Zotefoams' average media sentiment score of 1.61 beat Treatt's score of 0.00 indicating that Zotefoams is being referred to more favorably in the media.

Company	Overall Sentiment
Zotefoams	Very Positive
Treatt	Neutral

Treatt has lower revenue, but higher earnings than Zotefoams. Zotefoams is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£158.49M	1.33	£9.80M	£44.87	9.58
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24

Zotefoams has a net margin of 14.28% compared to Treatt's net margin of 3.40%. Zotefoams' return on equity of 18.25% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Treatt	3.40%	3.22%	6.72%

29.4% of Zotefoams shares are held by institutional investors. Comparatively, 17.5% of Treatt shares are held by institutional investors. 4.5% of Zotefoams shares are held by company insiders. Comparatively, 4.1% of Treatt shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Zotefoams beats Treatt on 13 of the 18 factors compared between the two stocks.

How does Zotefoams compare to Synthomer?

Synthomer (LON:SYNT) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

15.3% of Synthomer shares are owned by institutional investors. Comparatively, 29.4% of Zotefoams shares are owned by institutional investors. 5.0% of Synthomer shares are owned by company insiders. Comparatively, 4.5% of Zotefoams shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Synthomer currently has a consensus target price of GBX 86.75, indicating a potential upside of 6.44%. Zotefoams has a consensus target price of GBX 605, indicating a potential upside of 40.70%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts plainly believe Zotefoams is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -9.03%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-9.03%	-16.66%	-0.28%
Zotefoams	14.28%	18.25%	5.48%

Synthomer has a beta of 1.02, indicating that its stock price is 2% more volatile than the broader market. Comparatively, Zotefoams has a beta of 1.239, indicating that its stock price is 24% more volatile than the broader market.

In the previous week, Synthomer had 1 more articles in the media than Zotefoams. MarketBeat recorded 2 mentions for Synthomer and 1 mentions for Zotefoams. Zotefoams' average media sentiment score of 1.61 beat Synthomer's score of 0.34 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Synthomer	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Zotefoams	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.74B	0.08	-£82.04M	-£96.00	N/A
Zotefoams	£158.49M	1.33	£9.80M	£44.87	9.58

Summary

Zotefoams beats Synthomer on 13 of the 16 factors compared between the two stocks.

Get Zotefoams News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZTF vs. The Competition

Export

Metric	Zotefoams	Specialty Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£211.48M	£8.47B	£4.46B	£2.77B
Dividend Yield	1.79%	3.34%	5.04%	6.16%
P/E Ratio	9.58	15.87	20.49	368.03
Price / Sales	1.33	119.21	5,739.98	84,416.01
Price / Cash	18.87	19.67	24.07	27.89
Price / Book	1.74	3.39	8.48	7.61
Net Income	£9.80M	£213.62M	£157.08M	£5.89B
7 Day Performance	-0.23%	0.08%	-2.01%	-0.15%
1 Month Performance	-3.59%	-0.07%	-5.90%	-0.86%
1 Year Performance	33.54%	19.64%	34.65%	61.61%

Zotefoams Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
ZTF Zotefoams	4.294 of 5 stars	GBX 430 flat	GBX 605 +40.7%	+34.4%	£211.48M	£158.49M	9.58	549
VCT Victrex	1.1054 of 5 stars	GBX 716 +2.0%	GBX 674.29 -5.8%	+0.6%	£623.82M	£296.40M	N/A	1,109
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
ESNT Essentra	3.7134 of 5 stars	GBX 84.99 +0.9%	GBX 150 +76.5%	-14.7%	£240.93M	£302M	121.42	350
TET Treatt	N/A	GBX 305 flat	GBX 248.33 -18.6%	N/A	£180.06M	£128.29M	42.24	350

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:ZTF) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zotefoams (ZTF) Competitors